Rachel J. Church

Candidate biomarkers for the diagnosis and prognosis of drug‐induced liver injury: An international collaborative effort

Rachel J. Church, Gerd A. Kullak‐Ublick, Jiri Aubrecht et al. · Hepatology · 2018 · 231 citations · Full text

Cannabidiol and Abnormal Liver Chemistries in Healthy Adults: Results of a Phase I Clinical Trial

Paul B. Watkins, Rachel J. Church, Jie Li et al. · Clinical Pharmacology & Therapeutics · 2020 · 92 citations · Full text

Pharmacotherapy, Abnormal Liver Chemistries, Liver Safety Concerns +17

Sensitivity to hepatotoxicity due to epigallocatechin gallate is affected by genetic background in diversity outbred mice

Rachel J. Church, Daniel M. Gatti, Thomas Urban et al. · Food and Chemical Toxicology · 2014 · 90 citations · Full text

Application of a Mechanistic Model to Evaluate Putative Mechanisms of Tolvaptan Drug-Induced Liver Injury and Identify Patient Susceptibility Factors

Jeffrey L. Woodhead, William J. Brock, Sharin E. Roth et al. · Toxicological Sciences · 2016 · 89 citations · Full text

Immunology, Pharmacotherapy, Evaluate Putative Mechanisms +20

A Mutation in the Borcs7 Subunit of the Lysosome Regulatory BORC Complex Results in Motor Deficits and Dystrophic Axonopathy in Mice

John N. Snouwaert, Rachel J. Church, Leigh A. Jania et al. · Cell Reports · 2018 · 76 citations · Full text

Neurodegenerative Diseases, Molecular Neuroscience, Mouse Borcs7 Gene +14